Editorial Policy

Cloudcure publishes health information about metabolic and hormonal health, including obesity, type 2 diabetes, polycystic ovary syndrome (PCOS), metabolic syndrome, insulin resistance, and related conditions. This editorial policy describes how we source, write, review, and maintain that information so you can judge its trustworthiness.

Who writes our content

All clinical and health content on joincloudcure.com is authored by, or co-authored with, a named licensed clinician practising at Cloudcure. Every health page displays:

• The author’s full name and credentials
• Their provincial college registration (CPSO, CPSA, CPSBC, CMQ, or equivalent) with a link to the public register
• The name and credentials of the second clinician who medically reviewed the page
• The date the page was last clinically reviewed

Marketing and operational content (pricing, about, careers) is written by Cloudcure staff. These pages do not carry a clinical author byline because they do not provide clinical guidance.

How we review content

Every health article goes through a documented two-step review:

Step 1 — Clinical review. A second Cloudcure clinician (not the author) reviews the article for clinical accuracy, alignment with current Canadian guidelines (Diabetes Canada, Obesity Canada, Health Canada, and relevant specialty bodies), and PAAB-compliant language. The reviewer’s name and credentials appear on the page.

Step 2 — Editorial review. A Cloudcure editor reviews for plain-language clarity, structural completeness, citation integrity, and accessibility (reading level, image alt text, heading hierarchy).

The “Last reviewed” date on each article reflects the most recent clinical review.

How often we update

• Evergreen condition pages (obesity, PCOS, metabolic syndrome): clinically reviewed at least every 12 months, or sooner when material new evidence is published.
• Medication-adjacent content (where Schedule D / prescription drug categories are discussed): clinically reviewed at least every 6 months, or sooner when Health Canada updates the relevant Product Monograph.
• Time-sensitive content (new approvals, safety advisories): updated within 2 weeks of the underlying event.

When an article is updated, the “Last reviewed” date changes and a brief note may appear at the top describing what changed.

How we source our claims

We want you to be able to check anything we say. So we’re upfront about where our information comes from.

When we make a health claim — about a condition, a treatment, a medication, anything — we lean on (in this order):

1. The original research — peer-reviewed studies in indexed medical journals, especially randomized controlled trials and systematic reviews. These are the studies clinicians themselves rely on.
2. Canadian clinical practice guidelines — what our own specialty bodies recommend. That includes Diabetes Canada, Obesity Canada, the Canadian Cardiovascular Society, the Society of Obstetricians and Gynaecologists of Canada, and others.
3. Health Canada — the official Product Monographs (full prescribing information for every approved drug in Canada), safety advisories, and shortage notices.
4. Trusted international sources — when our Canadian guidelines line up with the WHO, NICE (UK), or the major American specialty bodies (ADA, AHA), we’ll sometimes cite those alongside.

What you won’t see us cite: random health blogs, manufacturer marketing copy, or anything we can’t trace back to a primary, indexed source. If we can’t show you where a claim came from, we don’t make it.

How we handle prescription medications

If you’re working with us on weight management or metabolic care, there’s a good chance prescription medication is part of the conversation. We want to be honest about how we talk about those medications on this website — because Canadian law actually limits what we can say in public.

In Canada, prescription drugs aren’t allowed to be marketed directly to consumers the way they are in the United States. The rules are set by Health Canada and the Pharmaceutical Advertising Advisory Board (PAAB), and they exist to protect you from drug ads that make treatment decisions feel like shopping decisions.

So on the public pages of this site, we deliberately:

• Don’t make efficacy or comparative claims about any branded medication. (Things like “X works better than Y” don’t belong on a public health site, even when there’s good evidence — that’s a conversation for you and your clinician.)
• Keep brand-name mentions minimal — usually just enough that you can find us when you’re searching. For the full clinical detail on any drug, we’ll point you to the Health Canada Product Monograph, which is the official source.
• Lead with the condition, not the drug. Our public articles focus on what we’re treating (obesity, PCOS, metabolic syndrome, type 2 diabetes) rather than on individual medications.

We do publish more detailed medication information — mechanism, dosing considerations, contraindications, the works — but that’s in a section of the site reserved for licensed healthcare professionals.

If you’re a Cloudcure patient and you want to understand a medication you’ve been prescribed, two good places to look:

• The Patient Medication Information leaflet that came with your prescription. It’s written specifically for you, in plain language, and includes everything you need to know about taking it safely.
• Your Cloudcure care team — through your patient portal. We’d rather you ask us than guess.

Conflicts of interest

Cloudcure Inc. is a private Canadian healthcare service. We hold no equity in any pharmaceutical manufacturer, and our clinicians are not paid by pharmaceutical companies in connection with prescribing decisions made at Cloudcure. Any clinician with a relevant external relationship (paid advisory roles, speakers’ bureaus, sponsored research) discloses that relationship on their public bio page on this site.

We do not accept advertising or sponsored content on joincloudcure.com.

Corrections and feedback

If you find an error — clinical, factual, citation, or accessibility — on any page on joincloudcure.com, please email care@joincloudcure.com with the URL and a description of the issue. We review all error reports within 5 business days. Substantive clinical corrections are republished with a dated note describing what was changed.

Patients who have concerns about clinical care received through Cloudcure should contact their Cloudcure care team directly through their patient portal, not via this address.

Accessibility

We aim for WCAG 2.2 AA conformance across joincloudcure.com. If you encounter an accessibility barrier, please report it to care@joincloudcure.com with the URL and a description of the barrier.

Governance

This editorial policy is owned by Cloudcure’s Medical Director and is reviewed at least annually. The current version was last reviewed on 2026-06-15.

---

Last reviewed: [set on publish] · Owned by: Medical Director, Cloudcure Inc. · Contact: care@joincloudcure.com